iGenix Debuts Illumina BeadXpress-based Warfarin PGx Test, Plans More Assays
July 26, 2011
iGenix Debuts Illumina BeadXpress-based Warfarin PGx Test, Plans More Assays
The assay, which genotypes two genes in order to guide dosing of the anticoagulant warfarin, is "one of several" in iGenix's pipeline, according to a company official.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- CGC Genetics Rolls out BeadXpress-based Test for Skeletal Dysplasia
July 17, 2012 / BioArray News - AmberGen Secures $600K to Develop Allergy Test on Illumina's BeadXpress Platform
May 15, 2012 / BioArray News - Illumina Hopes to Target $3B Molecular Dx Space with BeadXpress Tests
May 25, 2010 / BioArray News - Illumina Gets FDA Clearance for BeadXpress
May 4, 2010 / GenomeWeb Daily News - Illumina to Submit Cytogenetics Package to FDA, Commits to Using Arrays in Dx
January 26, 2010 / BioArray News